Equities

Jupiter Bioscience Ltd

JUPITER:NSI

Jupiter Bioscience Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)4.15
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 11 2013.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jupiter Bioscience Limited is an India-based company. The Company is engaged in the business of manufacturing peptide group products, drug intermediates, specialty, and fine chemicals. The generic names of certain products of the Company are 4-Chloro Resorcinol, ECCP Alanine, Dibenzyl Glycyl Salicylamide, and 3 4 5 Trimethoxy Benzaldehyde. Its subsidiaries include Sven Genetech Limited, Jupiter Bioscience Inc., and Jupiter Bioscience (HK) Ltd.

  • Revenue in INR (TTM)--
  • Net income in INR--
  • Incorporated1985
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Vilin Bio Med Ltd-100.00bn-100.00bn260.87m----3.05----------6.22------------------------0.9741--0.4159---4.27---72.38------
Jupiter Bioscience Ltd-100.00bn-100.00bn367.66m----------------------------5.42--5.61--61.37--17.32------10.4842.4329.3020.9222.8255.40-16.74
Vivimed Labs Ltd1.47bn-3.17bn410.42m607.00------0.2783-38.77-38.7717.88--------2,429,737.00---5.92---8.97-62.4633.74-214.73-14.20---6.31-----21.15-30.83-385.64------
JFL Life Sciences Ltd-100.00bn-100.00bn439.94m--------------------------------------------------8.63--50.42------
Vineet Laboratories Ltd1.71bn26.51m449.43m--16.89--8.720.26132.872.87185.24------------------24.80--1.55----2.08----11.05---81.13------
Data as of Jan 11 2013. Currency figures normalised to Jupiter Bioscience Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.